Medically actionable comorbidities in adults with Costello syndrome

Am J Med Genet A. 2020 Jan;182(1):130-136. doi: 10.1002/ajmg.a.61394. Epub 2019 Nov 3.

Abstract

Costello syndrome (CS) is an autosomal-dominant condition caused by activating missense mutations in HRAS. There is little literature describing health concerns specific to adults with CS. Parents of individuals with CS need to know what to anticipate as their children age. We surveyed a group of 20 adults and older adolescents with CS regarding their medical concerns and lifestyle characteristics. We identified several previously undescribed actionable medical concerns in adults with CS. First, the high prevalence of anxiety in this cohort indicates that screening for anxiety is warranted since this is a treatable condition that can have a significant impact on quality of life. Second, adults with CS should be monitored for progressive contractures or other problems that could decrease mobility. This is especially important in a population that seems to have increased risk for osteopenia. Finally, the lack of cancer diagnoses in adulthood is of interest, although the cohort is too small to draw definitive conclusions about cancer risk in adults with CS. Ongoing follow-up of the current cohort of adults with CS is necessary to delineate progressive medical and physical problems, which is essential for providing targeted management recommendations and anticipatory guidance to families.

Keywords: Costello syndrome; HRAS; adult.

MeSH terms

  • Adolescent
  • Adult
  • Anxiety / complications
  • Anxiety / epidemiology*
  • Anxiety / genetics
  • Anxiety / pathology
  • Bone Diseases, Metabolic / epidemiology
  • Bone Diseases, Metabolic / genetics
  • Bone Diseases, Metabolic / pathology
  • Child
  • Costello Syndrome / complications
  • Costello Syndrome / epidemiology*
  • Costello Syndrome / genetics
  • Costello Syndrome / pathology
  • Female
  • Humans
  • Male
  • Neoplasms / complications
  • Neoplasms / epidemiology*
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Phenotype
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Quality of Life
  • Young Adult

Substances

  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)